Drug Type Oncolytic virus |
Synonyms TGF- Trap Adenovirus, TGF-beta trap, ADAPT-001 + [1] |
Target |
Mechanism TGF-β inhibitors(Transforming growth factor beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chondrosarcoma | Phase 2 | US | 29 Mar 2021 | |
Soft Tissue Sarcoma | Phase 2 | US | 29 Mar 2021 |
NCT04673942 (ASCO2024) Manual | Phase 2 | 36 | AdAPT-001 monotherapy | analvsinnh(autrnejibv) = xmnywbjcqd icfoddxrqf (petimlgcky ) View more | Positive | 24 May 2024 | |
AdAPT-001 + CI combination | analvsinnh(autrnejibv) = aubprljjaw icfoddxrqf (petimlgcky ) View more | ||||||
AACR2024 Manual | Phase 2 | 36 | AdAPT-001 +/- ICI | mainwipefs(dsdbbryvjf) = mrrnyzqdfg lxdzgnwmkt (nvamlzxrce ) View more | Positive | 05 Apr 2024 | |
Phase 1 | 19 | pnfdbsupwm(vxcdkmqemi) = xqsopxrzec mjtpoggcjk (qoadmeybtn ) View more | Positive | 26 May 2023 |